Showing results (41-50 of 208) with videos related to
Sort By:
Pageof 21
BMC Research Notes|January 29, 2011
Label-free peptide profiling of Orbitrap™ full mass spectraMark K Titulaer, Dominique de Costa, Christoph Stingl, et al.Analytical Chemistry|July 14, 2015
Quantitative measurement of immunoglobulins and free light chains using mass spectrometryMartijn M VanDuijn, Joannes F M Jacobs, Ron A Wevers, et al.Biochemical and Biophysical Research Communications|June 21, 2005
Phosphorylation and binding partner analysis of the TSC1-TSC2 complexMark Nellist, Peter C Burgers, Ans M W van den Ouweland, et al.European Journal of Mass Spectrometry (Chichester, England)|July 16, 2016
Interaction of metal cations with functionalised hydrocarbons in the gas phase: further experimental evidence for solvation of metal ions by the hydrocarbon chainNick A van Huizen, Theo M Luider, Karl J Jobst, et al.ACS Omega|February 7, 2022
Effects of the IDH1 R132H Mutation on the Energy Metabolism: A Comparison between Tissue and Corresponding Primary Glioma Cell CulturesLennard J M Dekker, Cassandra Verheul, Nicky Wensveen, et al.Frontiers in Immunology|November 1, 2017
Immune Repertoire after Immunization As Seen by Next-Generation Sequencing and ProteomicsMartijn M VanDuijn, Lennard J Dekker, Wilfred F J van IJcken, et al.Journal of Pharmaceutical and Biomedical Analysis|May 23, 2016
A new quantification method for assessing plasma concentrations of pemetrexed and its polyglutamate metabolitesMarcel P Stoop, Sabine Visser, Evert van Dijk, et al.Frontiers in Oncology|October 29, 2020
Down-Regulation of Collagen Hydroxylation in Colorectal Liver MetastasisNick A van Huizen, Peter C Burgers, Joost van Rosmalen, et al.Journal of Pharmaceutical and Biomedical Analysis|October 2, 2017
High and individually variable enzymatic activity precludes accurate determination of pemetrexed, methotrexate and their polyglutamate metabolite concentrations in plasmaMarcel P Stoop, Sabine Visser, Evert van Dijk, et al.Journal of Proteome Research|January 24, 2013
Effects of natalizumab treatment on the cerebrospinal fluid proteome of multiple sclerosis patientsMarcel P Stoop, Vaibhav Singh, Christoph Stingl, et al.Pageof 21